CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients

Int J Mol Sci. 2023 Mar 24;24(7):6122. doi: 10.3390/ijms24076122.

Abstract

Cutaneous melanoma is a highly aggressive skin cancer, with poor prognosis. The tumor microenvironment is characterized by areas of hypoxia. Carbonic anhydrase IX (CA-IX) is a marker of tumor hypoxia and its expression is regulated by hypoxia-inducible factor-1 (HIF-1). CA-IX has been found to be highly expressed in invasive melanomas. In this study, we investigated the effects of hypoxia on the release of small extracellular vesicles (sEVs) in two melanoma in vitro models. We demonstrated that melanoma cells release sEVs under both normoxic and hypoxic conditions, but only hypoxia-induced sEVs express CA-IX mRNA and protein. Moreover, we optimized an ELISA assay to provide evidence for CA-IX protein expression on the membranes of the sEVs. These CA-IX-positive sEVs may be exploited as potential biomarkers for liquid biopsy.

Keywords: HIF-1; biomarker discovery; carbonic anhydrase IX; hypoxia; liquid biopsy; melanoma; sEVs.

MeSH terms

  • Antigens, Neoplasm / metabolism
  • Biomarkers, Tumor / metabolism
  • Carbonic Anhydrase IX / genetics
  • Carbonic Anhydrases* / metabolism
  • Humans
  • Hypoxia
  • Melanoma* / genetics
  • Melanoma, Cutaneous Malignant
  • Skin Neoplasms*
  • Tumor Microenvironment

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases
  • CA9 protein, human

Grants and funding

This research has received funding from the PROGETTO PNRR THE-TUSCANY HEALTH ECOSYSTEM—(SPOKE N. 7, CUP B63C22000680007 to F.C. (Fabio Carraro)).